Omeprazole DR Pellets

Product Overview

Omeprazole DR Pellets are designed for delayed oral delivery of Omeprazole, a proton pump inhibitor used to reduce gastric acid secretion in conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. Utilizing advanced pelletization technology combined with enteric polymer coatings, these pellets ensure protection from stomach acid and release the drug in the intestine for optimal absorption and therapeutic effect.

Product Name
Omeprazole DR Pellets
Strengths Available
7.5% - 20% (customizable as per formulation needs)
CAS No. / IUPAC Name
CAS: 73590-58-6 ; IUPAC: 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole
Molecular Formula / Weight
C17H19N3O3S / ~345.42 g/mol
Identification
Validated HPLC Method (USP/BP/EP compliant)
Release Type
Delayed Release (DR) – enteric-coated pellets designed to resist stomach acid and release drug in the intestines
Applications
Oral delayed-release formulations targeting acid-related gastrointestinal disorders
Storage Conditions
Store in a well-closed container in a cool, dry place, protected from light and moisture

Acetaminophen DC Granules – Typical Composition

Component	Function
Omeprazole	Active Pharmaceutical Ingredient (API)
Sugar Spheres / MCC Pellets	Inert core
Hypromellose (HPMC)	Binder
Methacrylic Acid Copolymers (Eudragit L/S)	Enteric polymers for acid-resistant delayed release coating
Polyvinyl Acetate Phthalate (PVAP)	Additional enteric coating polymer
Triethyl Citrate / Diethyl Phthalate	Plasticizer
Talc	Anti-adherent
Colloidal Silicon Dioxide	Glidant and anti-adherent
Purified Water / Isopropyl Alcohol	Solvent used for layering and coating
PEG (MW 4,000–20,000)	Dispersants for coating suspension
Tween-80	Emulsifiers for coating suspension

Why Choose Pellets from Salius Pharma?

Salius Pharma offers Omeprazole DR Pellets manufactured in USFDA-approved, WHO-GMP, and ISO-certified facilities in India. Our pellets are produced using advanced pelletization and acid-resistant enteric coating technologies to ensure reliable delayed release, enhanced stability, and improved bioavailability. Customizable strengths and pellet sizes facilitate flexible formulation design for effective treatment of acid-related disorders. Backed by robust global export experience and regulatory support, our pellets are optimized for seamless integration into oral delayed-release dosage forms worldwide.

Key Advantages of Partnering with Salius Pharma

Cost-Efficient Setup
Avoid heavy capital investment in infrastructure and workforce.
Guaranteed Quality Assurance
Products are sourced only from certified facilities with validated processes.
Access to Advanced Technology
Benefit from the latest drug delivery systems without managing the tech in-house.
Accelerated Market Entry
Launch products faster and establish your brand in less time.
Custom Formulation Support
Flexibility to offer tailored pellet solutions as per your market needs.

Expected Delivery Time

We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.

Place an Order or Request a Quote from Salius Pharma

Looking to source Omeprazole DR Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.

Get in Touch

Email: export@saliuspharma.com
Call / WhatsApp: +91 84258 80640 / +91 84258 80643
Landline: +91 22 49700 601 / +91 22 44503 148
Corporate Office: 3104–3106, Plan S Business Park, Nerul MIDC Opp. Dr. D.Y. Patil Stadium, Navi Mumbai – 400706, Maharashtra, India

Confidentiality Notice

The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.

Any patented products are excluded from our offerings in regions where such patents are currently in force.

FAQs

Omeprazole DR Pellets are delayed-release multiparticulate oral dosage forms designed to protect the drug from stomach acid and ensure targeted release in the intestine for optimal absorption and therapeutic effect.

Yes. These pellets are compatible with hard gelatin capsules, sachets, or multiparticulate formulations, offering flexibility for various oral delivery systems.

Salius Pharma provides custom drug loads, pellet sizes, coating types, and release profiles to meet specific formulation, regulatory, or market requirements.

All batches are manufactured under GMP conditions, tested for content uniformity, dissolution, and stability, and shipped with complete regulatory documentation (CoA, MSDS, stability reports) for safe international distribution.

Enquiry